Want to see CRON full AI Analyst Report?
Revenue by Segment
Analyzes revenue from different business segments, highlighting which areas are driving growth and which may need strategic adjustments.Revenue is increasingly concentrated in Cannabis Flower, which is the clear growth engine behind recent record quarters and international momentum; Cannabis Extracts are volatile and include a large negative outlier in 2025‑Q4 that likely represents a one‑off adjustment, making extract trends noisy, while Other is immaterial. Management’s plan to stabilize GrowCo capacity, broaden Puffers distribution and close the CanAdelaar deal should sustain flower-led top-line growth and margin recovery, but execution and European integration will determine whether margins actually expand.
Date | Other | Cannabis Flower | Cannabis Extracts |
|---|---|---|---|
Jun 30, 2026 | C$19.00K | C$39.21M | C$13.77M |
Mar 31, 2026 | C$19.00K | C$33.73M | C$11.46M |
Dec 31, 2025 | C$18.00K | C$33.74M | -C$26.55M |
Sep 30, 2025 | C$13.00K | C$26.36M | C$9.96M |
Jun 30, 2025 | C$70.00K | C$25.02M | C$8.36M |
Mar 31, 2025 | C$310.00K | C$23.34M | C$8.61M |
Dec 31, 2024 | C$315.00K | C$23.40M | C$6.59M |
Sep 30, 2024 | C$147.00K | C$26.33M | C$7.79M |
Jun 30, 2024 | C$37.00K | C$20.66M | C$7.06M |
Mar 31, 2024 | C$36.00K | C$17.52M | C$7.73M |